Albion Financial Group Prothena Corp Public LTD CO Transaction History
Albion Financial Group
- $1.48 Billion
- Q2 2025
A detailed history of Albion Financial Group transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Albion Financial Group holds 125 shares of PRTA stock, worth $942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$942
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
219Shares Held
34.1MCall Options Held
890KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$29.1 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$25.4 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$16.9 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$9.61 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $354M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...